Alyeska Investment Group
KPRX icon

Alyeska Investment Group’s Kiora Pharmaceuticals KPRX Stock Holding History

Alyeska Investment Group’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-76,904
Closed -$152K – 686
2025
Q4 		$152K Buy
+76,904
New +$175K ﹤0.01% 574
2024
Q4 		– Sell
-180,780
Closed -$662K – 614
2024
Q3 		$662K Hold
180,780
– – ﹤0.01% 478
2024
Q2 		$759K Sell
180,780
-63,664
-26% -$297K ﹤0.01% 483
2024
Q1 		$1.55M Buy
+244,444
New +$1.37M 0.01% 393

Other funds holding KPRX

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Alyeska Investment Group's KPRX Position: Q1 2026 in Review

Alyeska Investment Group sold out of Kiora Pharmaceuticals (KPRX) in Q1 2026, closing a stake of 76,904 shares — an estimated $152K sold.

Alyeska Investment Group first reported a position in KPRX in Q1 2024 and held it in 4 quarters. The position peaked at $1.55M in Q1 2024. 18 funds tracked by Wall St. Rank hold KPRX as of Q1 2026.

  • Alyeska Investment Group reported no remaining Kiora Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 76,904 Kiora Pharmaceuticals shares in Q1 2026, an estimated $152K.
  • Alyeska Investment Group first reported a position in Kiora Pharmaceuticals in Q1 2024 and held it in 4 quarters.
  • Alyeska Investment Group's Kiora Pharmaceuticals position peaked at $1.55M in Q1 2024.
  • 18 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.